Emergence of Biosimilar Medicines The Biosimilar Company Point of View Paul Greenland, Head of Biosimilars Business Unit - EMEA Belgium Federal Parliament

Source URL: www.egagenerics.com

• Medicine
• Pharmacology
• Biosimilar
• Biotechnology
• Drugs
• Cytokines
• Biologic
• Granulocyte colony-stimulating factor
• Erythropoietin
• Biology
• Amgen
• Growth factors

EuropaBio Statement on Labelling of Biosimilars September 2014 Transparent labelling is important to ensure that physicians and patients have readily available product-specific information about biosimilars, as is the ca

Source URL: www.europabio.org

• Biosimilar
• Drugs
• Clinical research
• Medicine
• Biologic
• Monoclonal antibodies
• Summary of Product Characteristics
• Biotechnology
• Pharmacology
• Biology

EGA-EBG SUMMARY POSITION REGARDING THE WHO BIOLOGIC QUALIFIER PROPOSAL (INN WORKING DOC[removed])  No additional component is needed in most jurisdictions as they manage very well with the brand name or INN accompanied

Source URL: www.egagenerics.com

• Becquerel
• Biologic
• Information
• Measurement
• Identifier
• Metadata

Production and Control of Biosimilars versus Innovators Antonio da Silva, Head Preclinical Development Hexal / Sandoz Biopharmaceuticals Lisbon, 03 April 2013 © 2013 Hexal AG, All rights reserved. All trademarks are the

Source URL: www.egagenerics.com

• Immune system
• Science
• Biosimilar
• Drugs
• Pharmacology
• Biologic
• Monoclonal antibodies
• Assay
• Surface plasmon resonance
• Biology
• Chemistry
• Biotechnology

CURRENT EUROPEAN REGULATORY FRAMEWORK FOR GENE THERAPY ECL Annual Conference State of the Art in Genetics, Genomics and Cancer Ljubljana, 28 November 2013

Source URL: www.europeancancerleagues.org

• Biotechnology
• Emerging technologies
• Clinical research
• European Medicines Agency
• Genetic engineering
• Biologic
• Gene therapy
• Viral vector
• Virology
• Biology
• Molecular biology
• Gene delivery

CDER Drug and non-Biosimilar Biologic INDs with Activity Report[removed]

Source URL: www.fda.gov

EUROPABIO_biosimilars_POSITION_20092014_EUROPABIO

Source URL: www.europabio.org

• Biosimilar
• Biotechnology
• Drugs
• Pharmaceutical industry
• Biologic
• Pharmacovigilance
• European Medicines Agency
• Pharmaceutical drug
• Alternative medicine
• Pharmacology
• Pharmaceutical sciences
• Clinical research

Market Access Factors Supporting a Sustainable European Biosimilar Medicines Market PROJECT SUMMARY FOR EXTERNAL COMMUNICATION

Source URL: www.egagenerics.com

• Pharmacy
• Biosimilar
• Biotechnology
• Drugs
• GfK
• Pharmaceutical industry
• Biologic
• Medicine in China
• Pharmacology
• Pharmaceutical sciences
• Clinical research

EUROPABIO_BROCHURE_biosimilars_01102014_EUROPABIO_Clinical_trials

Source URL: www.europabio.org

• Biosimilar
• Biologic
• European Medicines Agency
• Pharmacovigilance
• Pharmaceutical industry
• Food and Drug Administration
• Pharmaceutical medicine
• Reditux
• Hospira
• Pharmaceutical sciences
• Pharmacology
• Medicine

PDF Document

Source URL: media.wiley.com

• Pharmacology
• Cell biology
• Emerging technologies
• Cell therapy
• Biopharmaceutics Classification System
• Pharmaceutical Research
• Biologic
• Adult stem cell
• Metered-dose inhaler
• Biology
• Biotechnology
• Stem cells